• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪量和肥胖相关基因增强非酒精性脂肪性肝病中的氧化应激和脂肪生成。

Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease.

机构信息

Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu 210029, China.

出版信息

Dig Dis Sci. 2013 Apr;58(4):1004-9. doi: 10.1007/s10620-012-2516-6. Epub 2013 Jan 18.

DOI:10.1007/s10620-012-2516-6
PMID:23329013
Abstract

BACKGROUND AND AIM

Nonalcoholic fatty liver disease (NAFLD) is strongly associated with obesity, hyperlipidemia, and type 2 diabetes mellitus. Several studies have found that fat mass and the obesity-associated (FTO) gene is linked to obesity. The aim of this work is to investigate the expression and function of FTO in liver with lipid metabolism diseases.

METHODS

We investigated the basal FTO expression in an NAFLD rat model and compared it with control subjects. The function of FTO in lipid metabolism was further studied in L02 cells through overexpression experiments.

RESULTS

A significant increase in FTO mRNA and protein levels was found in the NAFLD group. In addition, the FTO levels were positively associated with malondialdehyde and superoxide dismutase concentrations. FTO overexpression in L02 cells enhanced lipogenesis and oxidative stress.

CONCLUSIONS

This study demonstrates that increased FTO levels in the liver are involved in oxidative stress and lipid deposition, which characterize NAFLD.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)与肥胖、高血脂和 2 型糖尿病密切相关。多项研究发现,脂肪量和肥胖相关(FTO)基因与肥胖有关。本研究旨在探讨 FTO 在伴有脂代谢疾病的肝脏中的表达和功能。

方法

我们检测了 NAFLD 大鼠模型中的基础 FTO 表达,并与对照组进行比较。通过过表达实验进一步研究了 FTO 在 L02 细胞中对脂代谢的作用。

结果

NAFLD 组 FTO mRNA 和蛋白水平显著升高。此外,FTO 水平与丙二醛和超氧化物歧化酶浓度呈正相关。L02 细胞中 FTO 的过表达增强了脂肪生成和氧化应激。

结论

本研究表明,肝脏中 FTO 水平的升高与 NAFLD 的特征性氧化应激和脂质沉积有关。

相似文献

1
Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease.脂肪量和肥胖相关基因增强非酒精性脂肪性肝病中的氧化应激和脂肪生成。
Dig Dis Sci. 2013 Apr;58(4):1004-9. doi: 10.1007/s10620-012-2516-6. Epub 2013 Jan 18.
2
Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease.艾塞那肽通过PI3K信号通路改善非酒精性脂肪性肝病中的肝脂肪变性,减轻脂肪量并降低FTO基因表达。
Braz J Med Biol Res. 2018;51(8):e7299. doi: 10.1590/1414-431x20187299. Epub 2018 Jun 14.
3
FTO promotes SREBP1c maturation and enhances CIDEC transcription during lipid accumulation in HepG2 cells.FTO 促进 SREBP1c 成熟,并在 HepG2 细胞脂质积累过程中增强 CIDEC 的转录。
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 May;1863(5):538-548. doi: 10.1016/j.bbalip.2018.02.003. Epub 2018 Feb 25.
4
Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.脂肪量和肥胖相关基因和叉头转录因子 O1 在非酒精性脂肪性肝病中的表达及意义。
Chin Med J (Engl). 2014;127(21):3771-6.
5
GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of mA on lipogenic mRNAs.GR 介导的 FTO 转录激活通过去甲基化脂肪生成 mRNA 上的 mA 诱导肝细胞中的脂质积累。
RNA Biol. 2020 Jul;17(7):930-942. doi: 10.1080/15476286.2020.1736868. Epub 2020 Mar 9.
6
FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction.在 2 型糖尿病中,FTO 在肌肉中增加,其在肌管中的过度表达改变了胰岛素信号,增强了脂肪生成和 ROS 产生,并诱导了线粒体功能障碍。
Diabetes. 2011 Jan;60(1):258-68. doi: 10.2337/db10-0281. Epub 2010 Oct 13.
7
Fat Mass and Obesity Associated () Gene and Hepatic Glucose and Lipid Metabolism.脂肪量和肥胖相关基因与肝脏葡萄糖和脂质代谢。
Nutrients. 2018 Nov 1;10(11):1600. doi: 10.3390/nu10111600.
8
In silico profiling of nonsynonymous SNPs of fat mass and obesity-associated gene: possible impacts on the treatment of non-alcoholic fatty liver disease.脂肪量和肥胖相关基因的非同义 SNPs 的计算机预测分析:对非酒精性脂肪性肝病治疗的可能影响。
Lipids Health Dis. 2023 Jan 30;22(1):17. doi: 10.1186/s12944-023-01782-7.
9
Fat mass and obesity-associated protein regulates lipogenesis via m A modification in fatty acid synthase mRNA.脂肪量和肥胖相关蛋白通过脂肪酸合酶 mRNA 的 mA 修饰来调节脂肪生成。
Cell Biol Int. 2021 Feb;45(2):334-344. doi: 10.1002/cbin.11490. Epub 2020 Nov 8.
10
Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.高脂饮食诱导肥胖和非酒精性脂肪性肝病小鼠肝脏和脂肪组织中调节脂肪生成的转录因子和基因表达改变。
Eur J Gastroenterol Hepatol. 2008 Sep;20(9):843-54. doi: 10.1097/MEG.0b013e3282f9b203.

引用本文的文献

1
Genetic Risk of MASLD in Mongolians: Role of and SNPs.蒙古族非酒精性脂肪性肝病的遗传风险: 及单核苷酸多态性的作用。
Curr Issues Mol Biol. 2025 Aug 1;47(8):605. doi: 10.3390/cimb47080605.
2
Comprehensive Analysis of Differentially Expressed Profiles of mRNA 5-Methylcytosine Modification in Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病中mRNA 5-甲基胞嘧啶修饰差异表达谱的综合分析
Curr Issues Mol Biol. 2025 Apr 26;47(5):305. doi: 10.3390/cimb47050305.
3
Interactions of spontaneous abortion with gene and dietary carotenoids; a case-control study.

本文引用的文献

1
Inflammatory markers in relation to nonalcoholic fatty liver disease in urban South Indians.印度南部城市居民非酒精性脂肪性肝病与炎症标志物的关系。
Diabetes Technol Ther. 2012 Feb;14(2):152-8. doi: 10.1089/dia.2011.0213. Epub 2011 Dec 7.
2
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.氧化应激在非酒精性脂肪性肝炎发病机制中的作用。
Free Radic Biol Med. 2012 Jan 1;52(1):59-69. doi: 10.1016/j.freeradbiomed.2011.10.003. Epub 2011 Oct 13.
3
Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments.
自然流产与基因及膳食类胡萝卜素的相互作用;一项病例对照研究。
J Nutr Sci. 2024 Nov 27;13:e75. doi: 10.1017/jns.2024.55. eCollection 2024.
4
N6-methyladenosine (m6A) modification in inflammation: a bibliometric analysis and literature review.炎症中的N6-甲基腺苷(m6A)修饰:文献计量分析与文献综述
PeerJ. 2024 Dec 13;12:e18645. doi: 10.7717/peerj.18645. eCollection 2024.
5
Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight.代谢功能障碍相关脂肪性肝病诱导的肝细胞癌中表观遗传学与代谢重编程之间的串扰:新视角
Metabolites. 2024 Jun 8;14(6):325. doi: 10.3390/metabo14060325.
6
The regulatory role of mA methylation modification in metabolic syndrome pathogenesis and progression.mA甲基化修饰在代谢综合征发病机制及进展中的调控作用。
Front Physiol. 2024 Mar 14;15:1271874. doi: 10.3389/fphys.2024.1271874. eCollection 2024.
7
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy.细胞代谢中的 RNA 修饰:对代谢靶向治疗和免疫治疗的影响。
Signal Transduct Target Ther. 2024 Mar 27;9(1):70. doi: 10.1038/s41392-024-01777-5.
8
Changes in m6A in Steatotic Liver Disease.脂肪性肝病中 m6A 的变化。
Genes (Basel). 2023 Aug 19;14(8):1653. doi: 10.3390/genes14081653.
9
Studies on the fat mass and obesity-associated (FTO) gene and its impact on obesity-associated diseases.脂肪量和肥胖相关(FTO)基因及其对肥胖相关疾病影响的研究。
Genes Dis. 2022 May 6;10(6):2351-2365. doi: 10.1016/j.gendis.2022.04.014. eCollection 2023 Nov.
10
N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment.N6-甲基腺苷 RNA 甲基化在肝脏疾病中的作用:从机制到治疗。
J Gastroenterol. 2023 Aug;58(8):718-733. doi: 10.1007/s00535-023-02008-4. Epub 2023 Jun 28.
非酒精性脂肪性肝病与心血管风险:代谢方面和新的治疗方法。
Endocrine. 2011 Dec;40(3):332-43. doi: 10.1007/s12020-011-9530-x. Epub 2011 Sep 6.
4
Non-Alcoholic Fatty Liver Disease (NAFLD) - Is it an Emerging Risk Factor for Coronary Artery Disease?: Preliminary study in a local Indian population.非酒精性脂肪性肝病(NAFLD)——它是冠状动脉疾病的一个新出现的危险因素吗?:对印度当地人群的初步研究。
Sultan Qaboos Univ Med J. 2010 Aug;10(2):221-6. Epub 2010 Jul 19.
5
Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis.炎症应激通过增加胆固醇摄取和从头合成加剧肝脏胆固醇积累。
J Gastroenterol Hepatol. 2011 May;26(5):875-83. doi: 10.1111/j.1440-1746.2010.06560.x.
6
PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver.过氧化物酶体增殖物激活受体-α 的表达可保护雄性小鼠免受高脂肪诱导的非酒精性脂肪肝的影响。
J Nutr. 2011 Apr 1;141(4):603-10. doi: 10.3945/jn.110.135210. Epub 2011 Feb 23.
7
Obesity-susceptibility loci have a limited influence on birth weight: a meta-analysis of up to 28,219 individuals.肥胖易感性基因座对出生体重的影响有限:多达 28219 个人的荟萃分析。
Am J Clin Nutr. 2011 Apr;93(4):851-60. doi: 10.3945/ajcn.110.000828. Epub 2011 Jan 19.
8
Risk of all-cause and cardiovascular mortality in patients with chronic liver disease.慢性肝病患者全因死亡率和心血管死亡率的风险
Gut. 2011 Nov;60(11):1602-3; author reply 1603-4. doi: 10.1136/gut.2010.230656. Epub 2010 Dec 15.
9
Genomics, type 2 diabetes, and obesity.基因组学、2型糖尿病与肥胖症
N Engl J Med. 2010 Dec 9;363(24):2339-50. doi: 10.1056/NEJMra0906948.
10
The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.脂质代谢在酒精性和非酒精性肝脂肪变性发病机制中的作用。
Semin Liver Dis. 2010 Nov;30(4):378-90. doi: 10.1055/s-0030-1267538. Epub 2010 Oct 19.